Androgens and estrogens may play a role in gastric cancer etiology. To investigate the association of gastric cancer with singlenucleotide polymorphisms (SNPs) in six genes (COMT, CYP1B1, CYP17A1, CYP19A1, HSD17B1 and SHBG) involved in estrogen and androgen synthesis and metabolism, 58 haplotype-tagging SNPs were genotyped in 295 gastric cancer cases and 415 controls from a population-based study in Poland. We assessed differences in haplotype frequency between cases and controls using a global score test and calculated multivariate odds ratios (ORs) and 95% confidence intervals (CIs) for individual haplotypes using logistic regression. We found associations in one linkage disequilibrium (LD) block containing the 3# untranslated region of COMT (rs9332377, rs165728, rs165849 and rs1110478), global score test (df 5 4, P 5 0.033). Relative to the most frequent GATA haplotype, the GATG haplotype was associated with statistically significant increased gastric cancer risk (OR 5 1.50, 95% CI: 1.06-2.12; false discovery rate (FDR) value 5 0.459) and the AACA haplotype with borderline increased risk (OR 5 1.36, 95% CI 5 1.00-1.85; FDR 5 0.50). We also found associations for the LD block containing part of the SHBG coding region (rs6258, rs6259, rs2955617, rs1641544 and rs1641537). The CACCC haplotype was associated with statistically significant lower gastric cancer risk relative to the referent CGACC haplotype (OR 5 0.55, 95% CI 5 0.34-0.90; FDR 5 0.459), but the overall score test was statistically non-significant. No other statistically significant associations were observed. In summary, we found possible associations between gastric cancer and polymorphisms in COMT, involved in estrogen inactivation, and SHBG, a modulator of hormone bioavailability. These findings should be interpreted cautiously until replicated in other studies.
Introduction
Gastric cancer is the second leading cause of cancer death worldwide (1) . Incidence rates vary widely by geographic area. Men are two times more likely to develop gastric cancer than women in both highand low-incidence areas (2) . The ratio of male to female cases is greatest during the reproductive years and become more similar after the age of 60, corresponding with menopause (2) . As normal and cancerous gastric tissue expresses steroid hormone receptors that bind to estrogens and androgens (3, 4) , one hypothesis suggests that sex hormones may play an etiological role in gastric cancer (2) . The overall results from nearly 10 epidemiologic studies that investigated associations between menstrual and reproductive factors and gastric cancer risk (5) (6) (7) (8) (9) (10) (11) (12) suggest an association between age of menopause, years of fertility or hormone replacement therapy and gastric cancer risk, although the associations did not reach statistical significance and case numbers were small in most studies. Two types of clinical data also support the hypothesis. Prostrate cancer patients treated with estrogen had reduced risk of developing gastric cancer (13) and women treated with the estrogen antagonist tamoxifen had a statistically non-significant increased risk of gastric cancer (14, 15) . Finally, male rats are more likely to develop gastric cancer than female rats; but tumor numbers become similar after male rats are treated with estrogen. Castrating male rats also lowers gastric cancer risk (16) . Similar results have been found in a mouse model of gastric cancer (17) .
A number of genes encode enzymes that synthesize and metabolize androgens and estrogens. CYP17A1 converts pregnenolone to dehydroepiandrosterone and progesterone to 17 alpha-hydroxyprogesterone (18) . CYP19A1 converts the androstenedione to estrone and testosterone to estradiol (19) . HSD17B1 converts androstenedione to testosterone and estrone to estradiol (19) . SHBG encodes a plasma glycoprotein that transports androgens and estrogens in the circulation and that regulates the availability of estrogens and androgens (20) . Among other functions, CYP1B1 and COMT convert estrogens to compounds that lack estrogenic activity. CYP1B1 catalyzes the C4 hydroxylation of estradiol to 4-hydroxy catechol estrogens, which can form adducts with DNA. COMT further metabolizes 4-hydroxy catechol estrogens into stable methylated catechol estrogens that do not form DNA adducts (21, 22) .
As androgens and estrogens may be related to gastric cancer risk, we hypothesized that genetic polymorphisms in these genes might be associated with gastric cancer.
Materials and methods

Study design
The methods of this population-based case-control study of gastric cancer have been described in detail previously (23) . Cases are Caucasian residents of Warsaw, Poland, aged 21-79 years, who were newly diagnosed with gastric cancer (ICD-0 151) between 1994 and 1996 and identified by physicians in each of the 22 hospitals serving the study area. All the cases were confirmed to be gastric adenocarcinoma by study pathologists. Controls were randomly selected from a computerized registry of Warsaw residents and frequency matched to cases by sex and 5 year age groups. Informed consent was obtainedof the stop codon was chosen. In addition to SNPs in the dbSNP database, SNPs in these regions were identified by sequencing a multiethnic panel of 190 breast and prostate cancer cases. Allele frequencies in Caucasians were calculated, and haplotypes were imputed by the expectation-maximization algorithm (26) . We genotyped previously published haplotype-tagging SNPs identified by the BPC3 to predict common haplotypes in Caucasians for CYP17A1 [two linkage disequilibrium (LD) blocks and nine SNPs, R have not yet been published. Details can be found on the website http://cgf1.nci.nih.gov/cohort.cfm. Two of three SNPs in LD block #1 of COMT failed validation and were not included. We did not analyze haplotypes in this block separately; to improve statistical efficiency without losing predictive power, we combined this block with LD blocks 2 and 3 into a single block. A previous report also analyzed LD blocks 1-3 as a single entity (31) .
As BPC3
had not yet chosen tagging SNPs for SHBG at the time of genotyping, nine SNPs were chosen by the NCI Core Genotyping Facility from BPC3 LD data using a pair-wise R 2 of !0.8 and .5% minor allele frequency in Caucasians with Tagzilla (http://tagzilla.nci.nih.gov/). The BPC3 identified three LD blocks in SHBG. To improve statistical efficiency, 
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we combined SHBG LD blocks #1 and #2 into a single block for analysis. One assay in SHBG failed validation (rs2908809). Of successfully genotyped SNPs in SHBG, rs12150660 had the highest pair-wise LD with rs2908809 (R 2 5 0.43), coverage of the remaining SNPs in SHBG did not change.
Genotyping
In total, 61 SNPs were genotyped in these six genes. All assays were performed at the NCI's Core Genotyping Facility; description, methods and validation data for the assays can be found at http://snp500cancer.nci.nih.gov. Each assay was sequence validated in the 102 samples of the NCI SNP500Cancer project (32) and additionally validated against 210 HapMap control subjects. Complete concordance was observed for all assays, except for rs174674 and rs5748489 in LD block #1 of COMT and rs2908809 in LD block #1 of SHBG. These assays, therefore, were not included in this study. Of the 58 validated assays, 38 polymorphisms were genotyped by SNPlex assay (Applied Biosystems, Foster City, CA) and the remaining 20 SNPs were genotyped by TaqMan (Applied Biosystems). At the laboratory, case-control status was masked and we included quality control samples from the NCI SNP500 project and blinded duplicate samples from our study. Concordance for the blinded quality control samples ($10% of samples) was .97%. Genotypes were successfully obtained from .94% of participants for all SNPs with a median completion rate of 98%. Table I presents details on genotyped SNPs, their chromosomal region and their refSNP number. Although we also genotyped rs605059 (HSD17B1), rs284849 (CYP17A1), rs2445765 (CYP19A1), rs28566535 (CYP19A1) and rs6493494 (CYP19A1), these SNPs were in strong LD (R 2 . 0.9) with rs598126, rs2486758, rs2446405, rs1902586 and rs749292, respectively, and were not further analyzed. We had sufficient DNA to genotype polymorphisms by TaqMan assays in 710 participants (415 controls and 295 cases), but SNPlex assays required more DNA and therefore these assays were restricted to 676 participants (391 controls and 285 cases). Associations between other covariates and gastric cancer did not change when analyses were restricted to those with a DNA sample (data not shown).
Statistical analysis
We tested for Hardy-Weinberg (HW) equilibrium in controls using an exact test (33) . All SNPs passed except for rs1110478 (P-value , 0.001) in COMT that was also out of HW equilibrium in Caucasians of the NCI SNP500 reference population (32) .
We examined pair-wise LD in controls using Haploview (34) . We used Haplo.Stats (version 1.3.1) (35) to compute common haplotype frequencies (those with 5% or greater frequency), odds ratios (ORs) and 95% confidence intervals (CIs) for haplotypes, assuming an additive model. Uncommon haplotypes (,5% prevalence) were included in the models as a single 'rare haplotypes category'. A global score test, adjusted for age, gender, education and smoking (never, former, current and pack-years among smokers) was used to evaluate the overall difference in haplotypes between cases and controls (36) . Alternative LD blocks defined within controls of our study (using a solid spline definition with D# , 0.80) gave similar results to those presented in this manuscript using BPC3-defined LD blocks.
For individual SNPs, we used unconditional logistic regression in SAS version 9.1 to estimate ORs and 95% CIs for the gastric cancer risk associated with a single copy or two copies of the minor allele relative to carrying no copies. We tested the null hypothesis of no association using a likelihood ratio test that compared models with and without the SNP in question.
All ORs were adjusted for age, gender, education (less than high school, high school or technical training and some college/college graduate) and smoking (never, former, current and pack-years among smokers). Further adjustment for other potential confounding variables including alcohol, caloric intake, intake of fruits, vegetables, sausages, red meats or preserved vegetables, family history of gastric cancer or other cancers, gastroesophageal reflux disease or Helicobacter pylori serology did not alter risk estimates. To examine the possible effect modification by sex, we inspected data for men and women separately and formally tested for differences using a likelihood ratio test. All tests were two sided and an alpha level of ,0.05 was considered statistically significant.
We evaluated the robustness of our findings by calculating the false discovery rate (FDR) (37) for both P-values from LD blocks and the P-value for trend of individual SNPs. Among all SNPs analyzed, FDR is the expected ratio of erroneous rejections of the null hypothesis to the total number of rejected hypotheses.
Results
By design, controls matched cases in their age and sex distribution. Cases smoked more and had less education than controls (Table II) .
We found no association with LD blocks in CYP1B1, CYP17A1, CYP19A1 or HSD17B1 (Table III) . In contrast, we found associations in one of two LD blocks in COMT and one of two LD blocks in SHBG. In COMT, a LD block (block #2) containing the 3# untranslated region (UTR) (rs9332377, rs165728, rs165849 and rs1110478) had a statistically significant global score test (P 5 0.033). This block had four common haplotypes with .5% prevalence. Relative to the most common haplotype (GATA), the GATG haplotype was associated with statistically significant increased risk of gastric cancer (OR: 1.50, 95% CI: 1.06-2.12), whereas the AACA haplotype had borderline increased risk (OR: 1.36, 95% CI: 1.00-1.85). For SHBG, LD block #2 (rs6258, rs6259, rs2955617, rs1641544 and rs1641537), which contains part of the SHBG coding region, had a statistically nonsignificant global score test (P 5 0.14), but the CACCC haplotype had statistically significant lower risk than the referent CGACC haplotype (OR: 0.55, 95% CI: 0.34-0.90).
We next examined the individual SNPs within the two LD blocks that showed evidence for an association with gastric cancer risk (block #2 in COMT and block #2 in SHBG) (Table IV) . For COMT, we found evidence for an association between gastric cancer risk and rs1110478 (OR per variant allele of 1.31, 95% CI: 1.02-1.67) and statistically non-significant increased risk with rs9332377 (OR per variant allele of 1.24, 95% CI: 0.93-1.67) and rs165849 (OR per variant allele of 1.23, 95% CI: 0.97-1.56). For SHBG, we found an association between rs6259 and gastric cancer risk (OR for GA/AA: 0.59, 95% CI: 0.36-0.96) and statistically non-significant reduced risk with rs2955617 (OR per variant allele of 0.81, 95% CI: 0.64-1.03). Individual data for all SNPs genotyped are presented in supplementary Table 1 (available at Carcinogenesis Online). We observed a statistically significant association between rs162557 (À2919C.T of CYP1B1) and gastric cancer risk (OR per variant allele of 0.74, 95% CI: 0.56-0.96). But, we did not observe evidence for an association of the LD block containing this SNP and gastric cancer risk (P 5 0.27).
We evaluated the robustness of our findings using the FDR method. The FDR value for LD block #2 in COMT was 0.429. For haplotypes, the FDR value was 0.459 for the GATG haplotype of COMT and the 
Discussion
We systematically investigated genetic variation in six genes (COMT, CYP1B1, CYP17A1, CYP19A1, HSD17B1 and SHBG) related to the synthesis and metabolism of estrogen and androgen using Table I and are presented 5#-3#. Haplotypes with ,5% frequency were grouped together and included in the models as one category, but are not presented here. b A global score test was used to evaluate the overall difference in haplotype frequency in cases and controls. haplotype-tagging SNPs (25) . We examined associations with gastric cancer risk using haplotype blocks and individual SNPs were merited. We found evidence for an association of gastric cancer risk with genetic polymorphisms in COMT and SHBG, but not with LD blocks in the other genes we examined. CYP1B1 and COMT sequentially metabolize estrogens into methylated catechol estradiols that lack estrogenic activity. We found a statistically significant global P-test for a haplotype block in COMT (block #2 in our analysis) and gastric cancer risk. These findings were consistent with the results of individual SNPs in this block, with one SNP (rs1110478) having a statistically significant positive association and two other SNPs (rs9332377 and rs165849) showing some evidence for an association. rs1110478 was out of HW equilibrium in both controls and cases of this study and also in the SNP500 Caucasian reference panel, with more individuals homozygous for the minor allele than expected (32) . This deviation from HW equilibrium could indicate a genotyping error and may increase the possibility that this association is due to chance (38) . But, the genotyping assay for rs1110478 was validated against sequencing in DNA samples from .300 individuals and found to be 100% concordant, genotyping completion rates were .95% and there were no discordant pairs for the blinded quality control samples ($10% of total samples), suggesting that these results are unlikely to be due to a genotyping error. By chance, we would expect that 5% of genotyped SNPs (two of 58 in this study) would be out of HW equilibrium. Two other SNPs (rs9332377 and rs165849) in this block showed increased but not statistically significant association with gastric cancer risk, providing some evidence that the association observed with rs1110478 is not due to a HW error.
No previous studies have examined the association of SNPs in LD block #2 of COMT and gastric cancer risk. Specific haplotypes in block #2 were previously shown to be associated with increased risk of breast cancer (31, 39) as well as other chronic diseases (40) . This LD block contains the 3# UTR of COMT. Though no in vitro data are available for these SNPs, 3# UTRs are important for the stability of many messenger RNA transcripts and thus could affect COMT expression. This genomic region also contains the 3# UTR of the neighboring armadillo repeat deleted in the velocardiofacial syndrome (ARVCF) gene that helps maintain adherens junctions (41) , another process that may be relevant to gastric cancer (42) .
We did not find associations between gastric cancer risk and LD block #1 of COMT, which overlaps the gene's coding region. SNPs within this region have been associated with increased risk of breast cancer in some studies, though the summary estimate from a recent meta-analysis does not support an association (43) . Recent data from a case-control study in Japan also did not observe an association between SNPs in this block and gastric cancer risk (44) .
SHBG is a plasma glycoprotein that transports androgens and estrogens while in circulation and regulates the availability of free estrogens and androgens (20) . Although the global P test was not statistically significant, one haplotype in LD block #2 in SHBG (CACCC) was associated with reduced risk of gastric cancer. This result was consistent with risk estimates for individual SNPs in this block, with those carrying the minor allele of rs6259 showing : rs6258/rs6259 (0); rs6258/rs2955617 (0.02); rs6258/rs1641544 (0); rs6258/rs1641537 (0); rs6259/rs2955617 (0.16); rs6259/rs1641544 (0); rs6259/ rs1641537 (0.01); rs2955617/rs1641544 (0.10); rs2955617/rs1641537 (0.28); rs1641544/rs1641537 (0.31).
Hormone-metabolizing SNPs and gastric cancer risk a statistically significant association. Though no previous studies have examined this SNP for gastric cancer, carrying the minor allele of rs6259 has been linked to decreased endometrial (45) and breast cancer risk (46) and increased risk of prostate cancer (47) in some studies, but not in others (48) (49) (50) . One study examined the association with ovarian cancer and found no association (51) .
rs6259 is a putatively functional SNP (D356N) that inserts an additional N-glycosylation site (52) and has been associated with modestly increased circulating levels of SHBG in those homozygous for the minor allele (50, 53, 54) . But, the association observed in this study was among heterozygotes, where circulating SHBG levels appear similar to those with the major allele (50, 53, 54) . Only one case and one control in this study were homozygous for the minor allele. rs6259 does not affect hormone binding (55) , but may affect other aspects including the transport of hormones into the cell (56) . SHBG may also regulate steroid signaling via alternative pathways, including regulating cyclic adenosine monophosphate levels by binding to its plasma membrane bound receptor (SHBG-R) (57, 58) . Alternatively, rs6259 could be in high LD with another functional polymorphism in SHBG or a neighboring gene.
We found no association between LD blocks in CYP1B1, CYP17A1, CYP19A1 and HSD17B1 and gastric cancer risk. Previous studies with hormonally associated cancers, such as breast or prostate, have not demonstrated consistent associations (27) (28) (29) (30) 49, 50) . One recent Japanese study observed statistically significant associations between several SNPs in CYP17A1 (rs619824 and rs743572) and CYP19A1 (rs4646 and rs1902586) and gastric cancer risk (44) that were also genotyped in our study. Our results did not replicate these findings.
Strengths of this study include its population-based design and comprehensive assessment of selected LD blocks, as well as use of haplotypes to limit the number of comparisons. Limitations include the exclusion of a larger percentage of cases (36%) than controls (14%) due to lack of DNA availability. Cases with a blood sample for DNA extraction had a lower tumor stage and grade than cases without a blood sample. If the association between genotypes or other exposures differed between more and less advanced cases, then the risk estimates observed in our study may not reflect the entire distribution of gastric cancer cases. But, the distribution of genotypes did not vary by tumor stage or grade in our study. In addition, demographic and lifestyle factors did not differ between cases and controls with and without a DNA sample, arguing against selection bias as a major determinant of our results.
An additional limitation is that our results are from a single modestly sized study. As we examined genetic variation in 13 LD blocks, statistically significant findings could be due to multiple comparisons and chance. Indeed, the most statistically significant LD block had a FDR of 0.429, the most statistically significant haplotype had a FDR of 0.459 and the most statistically significant individual SNPs had a FDR of 0.583. Therefore, our findings should be interpreted with caution and confirmed in additional studies. We also had limited power to examine associations in men and women separately.
In conclusion, in the first study to comprehensively examine the association of genetic variation in six genes of the steroid hormone metabolism pathway and gastric cancer risk, we found possible associations with genetic variation in COMT, involved in estrogen inactivation, and SHBG, a modulator of sex hormone bioavailability. We found no association with haplotypes in CYP1B1, CYP17A1, CYP19A1 and HSD17B1.
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